Associated Papers
Investigating the Impact of Dimer Interface Mutations on Norrin's Secretion and Norrin/β-Catenin Pathway Activation.
Liu M et al.
Investigative Ophthalmology & Visual Science, 2024
Selective Activation of the Wnt-Signaling Pathway as a Novel Therapy for the Treatment of Diabetic Retinopathy and Other Retinal Vascular Diseases.
Nguyen H et al.
Pharmaceutics, 2022
Spectrum of Mutations in NDP Resulting in Ocular Disease; a Systematic Review.
Wawrzynski J et al.
Frontiers in Genetics, 2022
Norrie disease with a spontaneously shrinking choroid plexus abnormality: a case report.
Younes ST et al.
Ophthalmic Genetics, 2021
TSPAN12 Is a Norrin Co-receptor that Amplifies Frizzled4 Ligand Selectivity and Signaling.
Lai MB et al.
Cell Reports, 2017
Familial cases of Norrie disease detected by copy number analysis.
Arai E et al.
Japanese Journal of Ophthalmology, 2014
Norrin stimulates cell proliferation in the superficial retinal vascular plexus and is pivotal for the recruitment of mural cells.
Zuercher J et al.
Human Molecular Genetics, 2012
TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signaling.
Junge HJ et al.
Cell, 2009
Select a paper to view details